AbbVie Inc (ABBV)
$294.89 +1.41% Close Oct 30, 2026 Live
AbbVie stock today
AbbVie closed at $294.89 on October 30, 2026, up 1.41% on the day. Over the past year it returned +33.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $521 billion.
$200.00$250.00$300.00
NovJan 2026MarMayJulSep
| Period | ABBV | S&P 500 (SPY) |
|---|---|---|
| 1 month | +13.4% | -0.9% |
| 3 months | +15.3% | +2.1% |
| Year to date | +32.9% | +11.7% |
| 1 year | +33.1% | +12.4% |
| 3 years | +129.8% | +88.5% |
| 5 years | +207.4% | +76.0% |
Key statistics
- Market value
- $521B
- P/E (trailing)
- 83.3
- Forward P/E
- 18.9
- Price / sales
- 8.1
- Dividend yield
- 2.35%
- 52-week range
- $197.38 to $294.89
About AbbVie
AbbVie develops and sells pharmaceutical products focused on immunology, virology, oncology, and women's health.
Sector: Health Care · Industry: Biotechnology
More on AbbVie
- Financials: revenue, earnings and segmentsRevenue +9% in the year to Dec 2025
- Valuation: P/E history and peersP/E 83.3, median 27.6 at its last 10 year ends
- Returns: what $1,000 became$1,000 ten years ago is $7,697 today
No forecast, no recommendation. This page describes AbbVie Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.